KV Pharmaceutical agreed to pay 17 million to settle multistate litigation alleging that it failed to advise the Centers for Medicare and Medicaid Services that two unapproved products did not qualify for coverage under federal and state health care programs. The settlement also involved the federal government, which issued its own announcement; ###-kv-pharmaceutical-company